{"filing":{"accession_number":"0001104659-26-070126","cik":"0001400118","ticker":"SGMT","company_name":"Sagimet Biosciences Inc.","form":"8-K","filing_date":"2026-06-03","report_date":null,"primary_document":"tm2616747d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1400118/000110465926070126/tm2616747d1_8k.htm"},"events":[{"id":3040,"run_id":2649,"accession_number":"0001104659-26-070126","anchor_item_number":"5.02","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The disclosure centers on compensatory arrangements granted to three named executives (David Happel, Thierry Chauche, and Elizabeth Rozek) on May 28, 2026: stock options and performance-based restricted stock units under the Company's 2023 Stock Option and Incentive Plan. This is a classic exec_compensation event involving equity grants with specified vesting schedules and performance conditions, not a departure or appointment.","company_name":"Sagimet Biosciences Inc.","ticker":"SGMT","filing_date":"2026-06-03","items":[{"id":3894,"accession_number":"0001104659-26-070126","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The disclosure centers on compensatory arrangements granted to three named executives (David Happel, Thierry Chauche, and Elizabeth Rozek) on May 28, 2026: stock options and performance-based restricted stock units under the Company's 2023 Stock Option and Incentive Plan. This is a classic exec_compensation event involving equity grants with specified vesting schedules and performance conditions, not a departure or appointment.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-04T02:19:09.024287+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":3894,"accession_number":"0001104659-26-070126","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The disclosure centers on compensatory arrangements granted to three named executives (David Happel, Thierry Chauche, and Elizabeth Rozek) on May 28, 2026: stock options and performance-based restricted stock units under the Company's 2023 Stock Option and Incentive Plan. This is a classic exec_compensation event involving equity grants with specified vesting schedules and performance conditions, not a departure or appointment.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-04T02:19:09.024287+00:00","company_name":"Sagimet Biosciences Inc.","ticker":"SGMT","filing_date":"2026-06-03"}]}